[go: up one dir, main page]

WO2001079438A3 - Nouveau polypeptide, proteine humaine de liaison 9 d'une proteine precurseur de l'amyloide, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, proteine humaine de liaison 9 d'une proteine precurseur de l'amyloide, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001079438A3
WO2001079438A3 PCT/CN2001/000530 CN0100530W WO0179438A3 WO 2001079438 A3 WO2001079438 A3 WO 2001079438A3 CN 0100530 W CN0100530 W CN 0100530W WO 0179438 A3 WO0179438 A3 WO 0179438A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotide encoding
amyloid precursor
human amyloid
protein
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000530
Other languages
English (en)
Chinese (zh)
Other versions
WO2001079438A2 (fr
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU73782/01A priority Critical patent/AU7378201A/en
Publication of WO2001079438A2 publication Critical patent/WO2001079438A2/fr
Publication of WO2001079438A3 publication Critical patent/WO2001079438A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une protéine humaine de liaison 9 d'une protéine précurseur de l'amyloïde, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de la maladie d'Alzheimer, des tumeurs malignes, de l'hémopathie, des troubles du développement, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine humaine de liaison 9 d'une protéine précurseur de l'amyloïde.
PCT/CN2001/000530 2000-03-29 2001-03-26 Nouveau polypeptide, proteine humaine de liaison 9 d'une proteine precurseur de l'amyloide, et polynucleotide codant pour ce polypeptide Ceased WO2001079438A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU73782/01A AU7378201A (en) 2000-03-29 2001-03-26 A novel polypeptide, a human 9-binding amyloid precursor protein and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115261.0 2000-03-29
CN00115261A CN1315439A (zh) 2000-03-29 2000-03-29 一种新的多肽——人淀粉类前体蛋白结合蛋白9和编码这种多肽的多核苷酸

Publications (2)

Publication Number Publication Date
WO2001079438A2 WO2001079438A2 (fr) 2001-10-25
WO2001079438A3 true WO2001079438A3 (fr) 2002-02-28

Family

ID=4584729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000530 Ceased WO2001079438A2 (fr) 2000-03-29 2001-03-26 Nouveau polypeptide, proteine humaine de liaison 9 d'une proteine precurseur de l'amyloide, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1315439A (fr)
AU (1) AU7378201A (fr)
WO (1) WO2001079438A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001429A1 (fr) * 1993-06-30 1995-01-12 Rhone-Poulenc Rorer S.A. Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodegeneratives
WO1997016458A1 (fr) * 1995-11-01 1997-05-09 Kos Pharmaceuticals, Inc. Apolipoproteine e2 et traitement de la maladie d'alzheimer
WO1998016557A1 (fr) * 1996-10-11 1998-04-23 The General Hospital Corporation Dosages pour recepteurs lies a la proteine g
WO2000002911A2 (fr) * 1998-07-10 2000-01-20 Curagen Corporation INTERACTION DE PRECURSEUR DE LA PROTEINE BETA-AMYLOIDE HUMAINE (β-APP) ET DE PROTEINE HUMAINE DU TYPE LON-PROTEASE (HsLON)

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001429A1 (fr) * 1993-06-30 1995-01-12 Rhone-Poulenc Rorer S.A. Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodegeneratives
WO1997016458A1 (fr) * 1995-11-01 1997-05-09 Kos Pharmaceuticals, Inc. Apolipoproteine e2 et traitement de la maladie d'alzheimer
WO1998016557A1 (fr) * 1996-10-11 1998-04-23 The General Hospital Corporation Dosages pour recepteurs lies a la proteine g
WO2000002911A2 (fr) * 1998-07-10 2000-01-20 Curagen Corporation INTERACTION DE PRECURSEUR DE LA PROTEINE BETA-AMYLOIDE HUMAINE (β-APP) ET DE PROTEINE HUMAINE DU TYPE LON-PROTEASE (HsLON)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CLAVERIE J.-M. AND MAKALOWSKI W.: "Alu alert", NATURE, vol. 371, 27 October 1994 (1994-10-27), pages 752, XP002070602 *
JURKA J. AND MILOSAVLJEVIC A.: "Reconstruction and analysis of human Alu genes", J. MOL. EVOL., vol. 32, no. 2, 1991, pages 105 - 121 *

Also Published As

Publication number Publication date
AU7378201A (en) 2001-10-30
WO2001079438A2 (fr) 2001-10-25
CN1315439A (zh) 2001-10-03

Similar Documents

Publication Publication Date Title
WO2001079438A3 (fr) Nouveau polypeptide, proteine humaine de liaison 9 d'une proteine precurseur de l'amyloide, et polynucleotide codant pour ce polypeptide
WO2001087961A1 (fr) Nouveau polypeptide, proteine pax humaine 11.4, et polynucleotide codant pour ce polypeptide
WO2001075037A3 (fr) Nouveau polypeptide, dihydroorotase humaine 40, et polynucleotide codant pour ce polypeptide
WO2001075027A3 (fr) Nouveau polypeptide, helicase humaine 13, et polynucleotide codant pour ce polypeptide
WO2001079435A3 (fr) Nouveau polypeptide, sous-unite humaine 14 de flavoproteine, et polynucleotide codant pour ce polypeptide
WO2001066585A8 (fr) Nouveau polypeptide, proteine humaine 10 regulant la protease, et polynucleotide codant pour ce polypeptide
WO2001046243A3 (fr) Nouveau polypeptide, proteine annulaire 8, et polynucleotide codant pour ce polypeptide
WO2002000822A3 (fr) Nouveau polypeptide, sous-unite humaine 2 $g(b) 16.5 du facteur d'initiation necessaire a la synthese proteique, et polynucleotide codant ce polypeptide
WO2001079426A3 (fr) Nouveau polypeptide, proteine humaine atm 20 de l'ataxie cinetique-telangiectasie, et polynucleotide codant pour ce polypeptide
WO2001075060A3 (fr) Nouveau polypeptide, cysteine protease humaine 9, et polynucleotide codant pour ce polypeptide
WO2001085903A3 (fr) Nouveau polypeptide, proteine humaine 9 contenant un fragment de sequence particulier de p5cr, et polynucleotide codant pour ce polypeptide
WO2001083685A3 (fr) Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2002000828A3 (fr) Nouveau polypeptide, proteine a doigt de zinc 34, et polynucleotide codant ce polypeptide
WO2001075059A3 (fr) Nouveau polypeptide, proteine humaine 11 de regulation de gtp, et polynucleotide codant pour ce polypeptide
WO2001075025A3 (fr) Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide
WO2002000821A3 (fr) Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide
WO2001075041A3 (fr) Nouveau polypeptide, proteine humaine associee a l'epilepsie 11, et polynucleotide codant pour ce polypeptide
WO2001075036A3 (fr) Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide
WO2001079427A3 (fr) Nouveau polypeptide, canal ionique humain 9 pour le chlore, et polynucleotide codant pour ce polypeptide
WO2001075012A3 (fr) Nouveau polypeptide, peptide signal humain 10 d'une proteine precurseur de la lipoproteine, et polynucleotide codant pour ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001083682A3 (fr) Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide
WO2001075058A3 (fr) Nouveau polypeptide, aminoacyl-arnt synthetase humaine 15 de type ii, et polynucleotide codant pour ce polypeptide
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP